Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic

The purpose of this study is to evaluate the effect of intravenous lidocaine infusion on pain and opioid dosage in patients undergoing single-port thoracoscopic surgery,and to evaluate the effects of perioperative catecholamine levels, extubation time, incidence of nausea and vomiting, patient satisfaction and hospital stay.

Panoramica dello studio

Stato

Sconosciuto

Condizioni

Intervento / Trattamento

Descrizione dettagliata

The World Congress on Pain identified pain as the "fifth leading indicator of human life" after breathing, pulse, body temperature and blood pressure. Postoperative pain is an acute nociceptive pain caused by surgical trauma and is a complex stress response in the body, especially in 72 hours after surgery. Pain after thoracic surgery is a more severe type of surgery in various types of surgery.

Acute pain at the early stage of operation is not only an external signal of body injury, but also an independent factor inducing stress response and systemic inflammatory response syndrome (SIRS). Pain stimulus can also cause excessive release of catecholamine, damage of vascular endothelial cells and neutrophil aggregation, which can induce cytokine "waterfall" secretion. Stress, pain and inflammation induce and interact with each other, which seriously affects the early recovery of patients after operation. Timely and effective post-operative analgesia can not only alleviate patients'pain, but also avoid a series of stress reactions. It provides favorable conditions for the stability of patients' physiological function and recovery of their body after operation.

Although multimodal analgesia has largely replaced monotherapy with opioids, they are still the most commonly used drugs for postoperative pain. Lidocaine is an amide local anesthetic which when used intravenously demonstrates significant analgesic, anti-hyperalgesic and anti-inflammatory properties .

Intravenous infusion of lidocaine has a good effect on fibromyalgia, chronic neuropathic pain, opioid tolerance and other chronic pain, and can reduce postoperative acute pain. In the 1960s, Barlett et al. first published a study on the use of lidocaine intravenous infusion for postoperative analgesia.Since then, more and more researchers have begun to explore the use of lidocaine in the treatment of postoperative acute pain.In 2007, Kaba et al. selected patients who underwent colectomy as an experimental subject, and intravenously injected lidocaine during the perioperative period. The results showed that the pain of the experimental group was effectively relieved and the use of opioids was reduced. In 2008, Lauwick et al. used laparoscopic cholecystectomy as the experimental subject. The results showed that the dose of opioid analgesia in the lidocaine group was significantly lower than that in the control group, and the postoperative pain was effectively improved. In 2009, Yardeni et al. selected patients undergoing total hysterectomy as experimental subjects and intravenously injected lidocaine during the perioperative period. The results confirmed that the hemodynamics of the experimental group was more stable, the average dosage of anesthetics was reduced, and the pain was significantly improved.However, to date, there is no strong evidence for the effect of perioperative intravenous infusion of lidocaine in single-port thoracoscopic surgery, so we designed this study.

Tipo di studio

Interventistico

Iscrizione (Anticipato)

80

Fase

  • Fase 4

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Zhejiang
      • Hangzhou, Zhejiang, Cina, 310009
        • Reclutamento
        • The Second Affiliated Hospital Zhejiang University School of Medicine
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 70 anni (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Patients undergoing single-port thoracoscopic with a left double lumen bronchial catheter
  • Age ≧ 18 years old, ≦70 years old
  • Temperature, white blood cells, and hemoglobin were normal before surgery
  • Patient informed consent

Exclusion Criteria:

  • Patients with a history of surgery within six months
  • Patients with dysfunction of heart, liver, kidney, lung, pancreas or other important organs
  • American Society of Anesthesiologists (ASA) physical Status classes ≧ Ⅲ
  • Allergic to lidocaine
  • Bradycardia (heart rate < 60 beats/min) or atrioventricular block
  • Mental disorder
  • Patients requiring a right double lumen bronchial catheter

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Lidocaine group
First group (lidocaine group) will include those who receive a intraoperative lidocaine infusion.Induction bolus dose of 1.5 mg/kg body weight ( 30 minutes before incision)followed by a continous lidocaine infusion of 2mg/kg/h,until 1 hours after skin closure.
regimen of lidocaine administration of 1.5 mg/kg, IV bolus, followed by continuous infusion at 2 mg/kg/h
Comparatore placebo: Saline group
The second group(saline group) will include those who receive a intraoperative placebo.The same dosage of saline was given according to the same method of administration in the lidocaine group.
IV bolus of saline, followed by continuous infusion of saline

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Postoperative pain score
Lasso di tempo: Immediately postoperation
Using Visual Analogue Scales
Immediately postoperation
Postoperative pain score
Lasso di tempo: 1 hour postoperation
Using Visual Analogue Scales
1 hour postoperation
Postoperative pain score
Lasso di tempo: 4 hours postoperation
Using Visual Analogue Scales
4 hours postoperation
Postoperative pain score
Lasso di tempo: 8 hours postoperation
Using Visual Analogue Scales
8 hours postoperation
Postoperative pain score
Lasso di tempo: 24 hours postoperation
Using Visual Analogue Scales
24 hours postoperation
Postoperative pain score
Lasso di tempo: 48 hours postoperation
Using Visual Analogue Scales
48 hours postoperation

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Opioid requirement
Lasso di tempo: Immediately postoperation
The dosage of opioids was recorded
Immediately postoperation
Opioid requirement
Lasso di tempo: 1 hour postoperation
The dosage of opioids was recorded
1 hour postoperation
Opioid requirement
Lasso di tempo: 4 hours postoperation
The dosage of opioids was recorded
4 hours postoperation
Opioid requirement
Lasso di tempo: 8 hours postoperation
The dosage of opioids was recorded
8 hours postoperation
Opioid requirement
Lasso di tempo: 24 hours postoperation
The dosage of opioids was recorded
24 hours postoperation
Opioid requirement
Lasso di tempo: 48 hours postoperation
The dosage of opioids was recorded
48 hours postoperation
Pressing times of PCIA postoperation
Lasso di tempo: 48 hours postoperation
The pressing times of PCIA within 48 hours postoperation was recorded
48 hours postoperation
Occurrence of nausea and/or vomiting
Lasso di tempo: 48 hours postoperation
The occurrence of nausea and vomiting within 48 hours postoperation was recorded
48 hours postoperation
Blood level of adrenaline
Lasso di tempo: before induction
Perioperative blood level of adrenaline was recorded
before induction
Blood level of adrenaline
Lasso di tempo: after incision
Perioperative blood level of adrenaline was recorded
after incision
Blood level of adrenaline
Lasso di tempo: immediately after extubation
Perioperative blood level of adrenaline was recorded
immediately after extubation
Blood level of norepinephrine
Lasso di tempo: before induction
Perioperative blood level of norepinephrine was recorded
before induction
Blood level of norepinephrine
Lasso di tempo: after incision
Perioperative blood level of norepinephrine was recorded
after incision
Blood level of norepinephrine
Lasso di tempo: immediately after extubation
Perioperative blood level of norepinephrine was recorded
immediately after extubation
Blood level of adrenocortical
Lasso di tempo: before induction
Perioperative blood level of adrenocortical was recorded
before induction
Blood level of adrenocortical
Lasso di tempo: after incision
Perioperative blood level of adrenocortical was recorded
after incision
Blood level of adrenocortical
Lasso di tempo: immediately after extubation
Perioperative blood level of adrenocortical was recorded
immediately after extubation
Blood level of TNF-alpha
Lasso di tempo: before induction
Perioperative blood level of TNF-alpha was recorded
before induction
Blood level of TNF-alpha
Lasso di tempo: after incision
Perioperative blood level of TNF-alpha was recorded
after incision
Blood level of TNF-alpha
Lasso di tempo: immediately after extubation
Perioperative blood level of TNF-alpha was recorded
immediately after extubation
Blood level of IL-6
Lasso di tempo: before induction
Perioperative blood level of IL-6 was recorded
before induction
Blood level of IL-6
Lasso di tempo: after incision
Perioperative blood level of IL-6 was recorded
after incision
Blood level of IL-6
Lasso di tempo: immediately after extubation
Perioperative blood level of IL-6 was recorded
immediately after extubation
Blood level of IL-10
Lasso di tempo: before induction
Perioperative blood level of IL-10 was recorded
before induction
Blood level of IL-10
Lasso di tempo: after incision
Perioperative blood level of IL-10 was recorded
after incision
Blood level of IL-10
Lasso di tempo: immediately after extubation
Perioperative blood level of IL-10 was recorded
immediately after extubation
Duration of hospital stay
Lasso di tempo: from day of surgery until day of discharge from hospital
length of hospital stay (in days)
from day of surgery until day of discharge from hospital

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Investigatori

  • Cattedra di studio: Congcong Chen, Second Affiliated Hospital, School of Medicine, Zhejiang University

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Anticipato)

1 agosto 2019

Completamento primario (Anticipato)

31 dicembre 2019

Completamento dello studio (Anticipato)

31 dicembre 2020

Date di iscrizione allo studio

Primo inviato

19 luglio 2019

Primo inviato che soddisfa i criteri di controllo qualità

31 luglio 2019

Primo Inserito (Effettivo)

2 agosto 2019

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

2 agosto 2019

Ultimo aggiornamento inviato che soddisfa i criteri QC

31 luglio 2019

Ultimo verificato

1 luglio 2019

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 2019-084

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .